跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LYRICA 300 MG CAPSULAS DURAS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
LYRICA 300 MG CAPSULAS DURAS
Approved
STANDARD
LYRICA 300 MG CAPSULAS DURAS
Upjohn Eesv
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 26, 2021
Approval ID
e77ba95c3a0d8cc1
Company
Upjohn Eesv
Type
Standard
Approval Details
Approval Id
e77ba95c3a0d8cc1
Drug Cima Aemps Name
LYRICA 300 MG CAPSULAS DURAS
Register Number
04279024IP
Holder Company Name
Upjohn Eesv
Marketing Company Name
Melyfarma S.L.
Holder Company Detail Path
/organization/upjohn-eesv
Authorization Date
2021-03-26
Dosage Form
CÁPSULA DURA
Dose
300 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Upjohn Eesv
Company Detail Path
/organization/upjohn-eesv
Company Information
Pharmaceutical Company Name
Upjohn EESV
Country Name
Netherlands
Active Ingredients
PREGABALINA
300 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 26, 2021
Approval ID
e77ba95c3a0d8cc1
Type
Standard
Back to CIMA-AEMPS Approvals